Fabtech Technologies Limited IPO
Fabtech Technologies Limited is a leading provider of turnkey engineering solutions, specializing in the pharmaceutical, biotech, and healthcare sectors. The company offers comprehensive services ranging from design and construction to equipment procurement, installation, and commissioning. With a global presence, Fabtech is involved in executing projects across over 62 countries, focusing on key emerging economies like India, Saudi Arabia, Egypt, Nigeria, and South Africa.
Services and Specializations
Fabtech specializes in providing integrated solutions that cover the entire lifecycle of a project. Their offerings include:
1. Design and Engineering: Tailored design and engineering solutions for pharmaceutical, biotech, and healthcare facilities.
2. Procurement: Efficient procurement processes, including sourcing equipment and materials for projects.
3. Construction and Commissioning: Expertise in the construction and commissioning of facilities, ensuring regulatory compliance.
4. Greenfield and Brownfield Projects: Capabilities extend to both new projects and upgrades to existing facilities.
5. Renewable Energy Projects: Involvement in the construction of Compressed Bio-Gas (CBG) plants and renewable energy solutions.
Global Presence and Market Leadership
Fabtech has successfully executed 51 projects across countries like Saudi Arabia, Egypt, Sri Lanka, and Kenya. The company has a strong order book and a well-established reputation in the industry, particularly in the renewable energy and pharmaceutical sectors.
Subsidiaries and Affiliations
Fabtech operates subsidiaries such as FT Institutions Private Limited and Fabtech Technologies LLC, based in Sharjah, along with other associate companies, ensuring its global reach and operational efficiency.
Core Strengths
i) Multidisciplinary Expertise: Fabtech’s team brings over three decades of experience in project management, design, and execution in pharmaceutical and biotechnology sectors.
ii) End-to-End Solutions: From project conception to completion, Fabtech provides a seamless process, including disease identification, facility design, engineering, and post-project support.
iii) Technological Integration: The company uses advanced technologies for project management and execution, such as their in-house software ‘FabAssure’ for efficient planning and issue resolution.
iv) Asset-Light Approach: Fabtech relies on partnerships with related entities and contractors, enabling them to scale operations effectively without heavy capital expenditure.
Objects of the Fabtech Technologies Limited IPO:
Fabtech Technologies Limited IPO Details:
Open Date: | Sep 29 2025 |
Close Date: | Oct 01 2025 |
Total Shares: | 1,20,60,000 |
Face Value: | ₹ 10 Per Equity Share |
Issue Type: | Book Building |
Issue Size: | 230.35 Cr. |
Lot Size: | 75 Shares |
Issue Price: | ₹ 181-191 Per Equity Share |
Listing At: | NSE,BSE |
Listing Date: | Oct 07 2025 |
Promoters And Management:
Financials of Fabtech Technologies Limited IPO:
To be updated shortly
Comparison With Peers:
To be updated shortly
Lead Manager of Fabtech Technologies Limited IPO:
Registrar of Fabtech Technologies Limited IPO:
Discussion on Fabtech Technologies Limited IPO:
Leave a Reply
You must be logged in to post a comment.